Skip to content
Medical Health Aged Care

Galderma launches new ALASTIN Restorative Skin Complex with Next Generation TriHex Technology®

Galderma Group AG 3 mins read

ALASTIN by Galderma, a leader in professional grade skincare, unveils its latest innovation clinically proven to help rejuvenate skin


ZUG, Switzerland--BUSINESS WIRE--

Galderma Group AG (SWX:GALD), the pure-play dermatology category leader, announced today that ALASTIN, a leader in medical-grade peptide-based regenerative skincare, has officially launched their latest skincare innovation with the introduction of Restorative Skin Complex with Next Generation TriHex Technology® (TriHex+™). This newly enhanced formula can be used as a multi-functional, daily rejuvenating serum to support the skin’s natural collagen and elastin production that declines from aging as well as the visible loss of volume in skin impacted by factors such as facial aging or medication-driven weight loss. Restorative Skin Complex with TriHex+ joins ALASTIN’s other world class and award-winning products that are science-led and physician-endorsed.

The much-loved Restorative Skin Complex formula has been enhanced with two groundbreaking additions. The first is an innovation to the patented TriHex Technology with the addition of Octapeptide-45, a proprietary, patent-pending peptide that amplifies the skin’s natural ability to regenerate collagen and elastin addressing the appearance of fine lines, radiance, skin plumping and long-lasting hydration. In addition, the new formula includes a novel ingredient, Magnolol, which helps stimulate depleted fat tissue (adipocytes). These new ingredients help to visibly restore desired facial radiance and plumping by supporting the skin’s own regenerative abilities that decline as we age, especially from age of 25 and up, when we begin losing around 1% of our collagen a year.1

 Galderma’s team is constantly evaluating unmet skin care needs and how we can elevate our products to address them. Concerns like loss of collagen and elasticity, along with the loss of volume as a result of medication-driven weight loss or other factors, have been at the forefront of patient concerns with their skin specialists. We knew we had to do more to help restore their ‘good fat’ while also regenerating the collagen and elastin that can degrade over time.”

 

ALAN D. WIDGEROW, MBBCH, MMED, FCS, FACS

CHIEF SCIENTIFIC OFFICER GALDERMA, HEAD SKIN SCIENCE
CENTER FOR INNOVATION, HEAD ALASTIN INNOVATIONS

 

ALASTIN will be launching the newly enhanced Restorative Skin Complex with TriHex+ this month in the United States. It will be available exclusively from authorized ALASTIN skincare providers at dermatology offices, clinics and medispas. Galderma is working to bring this new innovation to other international markets where ALASTIN is already available.

 Adding ingredients to further support the appearance of elasticity and skin volumization to a much-loved product that already delivers anti-aging, hydration, and visible volume facial plumping benefits represents a significant clinical and scientific breakthrough.”

 

DEANNE MRAZ, MD, FAAD

PRESIDENT AND FOUNDER, DMR RESEARCH

PRESIDENT AND CO-FOUNDER, MODERN DERMATOLOGY

ASSISTANT CLINICAL PROFESSOR OF DERMATOLOGY, YALE NEW HAVEN HOSPITAL

 

About Galderma

Galderma (SWX: GALD) is the pure-play dermatology category leader, present in approximately 90 countries. We deliver an innovative, science-based portfolio of premium flagship brands and services that span the full spectrum of the fast-growing dermatology market through Injectable Aesthetics, Dermatological Skincare and Therapeutic Dermatology. Since our foundation in 1981, we have dedicated our focus and passion to the human body’s largest organ – the skin – meeting individual consumer and patient needs with superior outcomes in partnership with healthcare professionals. Because we understand that the skin we are in shapes our lives, we are advancing dermatology for every skin story. For more information: www.galderma.com.

15 Signs Your Skin Is Losing Collagen | Vogue


Contact details:

For further information:

Christian Marcoux, M.Sc.
Chief Communications Officer
[email protected]
+41 76 315 26 50

Richard Harbinson
Corporate Communications Director
[email protected]
+41 76 210 60 62

Jeffrey Smith
Head of U.S. Communications
[email protected]
+1 (682) 401-8428

Media

More from this category

  • Medical Health Aged Care
  • 12/12/2025
  • 10:11
Cosette Pharmaceuticals, Inc.

Termination of Proposed Acquisition of Mayne Pharma

BRIDGEWATER, N.J.–BUSINESS WIRE– Cosette Pharmaceuticals, Inc. (Cosette), a U.S.-based, fully integrated pharmaceutical company, confirms that on 9 December 2025 it served a notice on…

  • Contains:
  • Medical Health Aged Care
  • 12/12/2025
  • 08:55
Royal Australian College of GPs

Universal Health Coverage Day: RACGP calls out need for better funding for chronic conditions and preventive care

Specialist GPs have marked International Universal Health Coverage (UHC) Day by joining the World Health Organization in highlighting the devastating impact of health costs. The Royal Australian College of GPs (RACGP) has stressed that a public health system which forces patients with complex or chronic conditions to pay out of pocket for longer consultations can’t claim to offer universal coverage, and urged governments to protect patients from financial hardship. “Health is a human right,” RACGP President Dr Michael Wright said. “Australia recognises the right of everyone to the highest attainable standard of physical and mental health, and our governments are…

  • Contains:
  • Medical Health Aged Care, Women
  • 12/12/2025
  • 01:00
Breast Cancer Trials

Simple blood tests could help tailor treatment for aggressive breast cancer

Key Facts: Blood tests detecting circulating tumour DNA could help guide treatment for triple negative breast cancer patients Absence of tumour DNA in blood…

  • Contains:

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.